Armistice Capital, LLC Neuro Pace Inc Transaction History
Armistice Capital, LLC
- $5.71 Billion
- Q2 2025
A detailed history of Armistice Capital, LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 1,152,335 shares of NPCE stock, worth $10.5 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
1,152,335
Previous 1,153,614
0.11%
Holding current value
$10.5 Million
Previous $14.2 Million
9.45%
% of portfolio
0.22%
Previous 0.22%
Shares
4 transactions
Others Institutions Holding NPCE
# of Institutions
108Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Orbimed Advisors LLC San Diego, CA2.61MShares$23.9 Million1.04% of portfolio
-
Morgan Stanley New York, NY2.59MShares$23.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.31MShares$21.1 Million2.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$12.6 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$12.5 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $227M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...